AXAxinet
Menu
Finance

Live market screen

Commercial Space Company Risk / Opportunity Ranking

Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.

Updated June 27, 2026

Companies analyzed
438
Ranked rows
876
Evidence links
356
Rows per page
20

Opportunity view

Showing rows 361-380 of 438; 20 rows per page.

Sorted by raw opportunity score
RankCompanyScoreThesis / Evidence
361
Romanian InSpace Engineering
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources only provides older membership context that Romanian InSpace Engineering was part of the consortium that developed the EMISAR satellite via article; that is insufficient for a current positive thesis within this ranking window.

Why now: No why-now catalyst is evidenced because there are no retained 90-day evidence.

Caveats: Reviewed evidence references but provides no. Single historical membership-support mention only. No retained evidence after recent evidence window.

362
Safran
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources does not provide direct positive company-specific evidence within the available 90-day evidence set. Only older or contextual references are cited in the membership rationale, including thematic propulsion or battery market reports and a reference to expanded small-satellite propulsion manufacturing, but no direct post-recent evidence window evidence is available for scoring.

Why now: There is no current catalyst in the reviewed sources. Coverage debug shows 270 article IDs considered but 0 article IDs after recent evidence window and 0 evidence available after dedupe, so recency-based thesis formation is not supported.

Caveats: Membership rationale references article IDs 2026-04, and, but no are provided in the reviewed sources, so they cannot be cited as factual scoring evidence under the the evidence standard. Evidence recent evidence review shows 0 kept rows after the 90-day cutoff.

363
SatLeo Labs
lowweak
Opp 1
Risk 1

Thesis: Reviewed evidence rationale says SatLeo Labs raised seed funding for a multispectral and thermal Earth observation constellation, but no retained article/evidence are available here to support a stronger opportunity ranking.

Why now: No retained within the recent evidence window evidence are provided, so there is no reviewed sources-supported why-now beyond cohort inclusion rationale.

Caveats: Only membership rationale is available; no citeable retained evidence. Small-company universe but zero available evidence after recent evidence window.

364
SciTec
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources say AI software came from a SciTec subsidiary in connection with Firefly's lunar imaging service, but this is only supporting article context without retained direct evidence, so it does not support a strong long-horizon opportunity thesis for SciTec itself.

Why now: No current catalyst is established because the reviewed sources retains no company-specific evidence after the 90-day filter.

Caveats: Phase-2 rationale references, but no or retained summary is available in the reviewed sources. Support level is provisional single-article context. No direct company-specific positive or negative evidence remain after recent evidence window.

365
SEALSQ Corp
lowweak
Opp 1
Risk 2

Thesis: Reviewed evidence membership rationale says SEALSQ is directly involved with WISeSat in a planned 100-satellite QSOC constellation and post-quantum satellite launches, which could indicate long-horizon strategic relevance, but no usable direct positive evidence or article survive the 90-day served evidence set in these reviewed sources.

Why now: Why now is weak because the 90-day reviewed sources contain no available evidence after recent evidence window for SEALSQ, despite article history existing in the broader corpus.

Caveats: No direct positive or negative evidence available after recent evidence window. Membership rationale references article IDs and, but the reviewed sources provide no for them, so they cannot be cited as factual support under the the evidence standard.

366
SEALSQ Corp
lowweak
Opp 1
Risk 1

Thesis: Reviewed evidence context links SEALSQ to post-quantum payload development with WISeSat, but there is no retained direct positive evidence inside the 90-day recent evidence window to support a 1 year+ opportunity thesis.

Why now: There is no usable current evidence because articles after recent evidence window = 0 and evidence after recent evidence window = 0 following the March 29, 2026 cutoff.

Caveats: No surviving recent evidence window-qualified evidence. Space relevance in reviewed sources rationale does not establish direction.

367
SES S.A.
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources membership rationale places SES in satellite communications and infrastructure contexts, but there are no available within the recent evidence window evidence or article details to support a directional opportunity thesis for this screen.

Why now: Why-now is weak because no reviewed evidence are available after recent evidence window, so recency and catalysts cannot be assessed from the reviewed sources.

Caveats: Membership rationale references and, but no corresponding available article summaries or evidence are provided. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Cohort membership does not establish opportunity.

368
Sidus Space Inc.
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources' membership rationale references payload and agreement expansion activity, but no retained within the recent evidence window direct evidence or article summaries are available here to support a positive investment-style thesis.

Why now: There is no retained dated company evidence after the 90-day recent evidence window; timing support for a 1 year+ thesis is absent in the reviewed sources.

Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. The membership rationale mentions article IDs, and, but no or retained evidence content are provided in these reviewed sources.

369
SkyFi
lowweak
Opp 1
Risk 1

Thesis: No direct positive evidence is available, so there is no supportable upside thesis from these reviewed sources alone.

Why now: Membership rationale says SkyFi was mentioned as a commercial access partner for Vantor's satellite imagery constellation in article, but this is only contextual and no or direct evidence are provided.

Caveats: Partner context is weaker than direct company evidence. No evidence available after recent evidence filtering. Referenced has no in the reviewed sources.

370
Skyfora
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources only says Skyfora appears in a funding roundup with a €6.5M raise, but no retained direct evidence or article summaries are provided after the 90-day recent evidence window, so there is not enough evidence to support a positive 1 year+ thesis.

Why now: No within the recent evidence window company-specific catalyst is provided. The reviewed sources reports zero reviewed evidence after the 90-day cutoff for Skyfora, so recency is insufficiently grounded.

Caveats: Phase-2 rationale references a €6.5M raise tied to: but no representative article, or retained evidence row is provided in these reviewed sources, so it cannot be used as direct scored evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership review status is not directional proof.

371
Solestial Inc.
lowweak
Opp 1
Risk 1

Thesis: No positive thesis is supportable from these reviewed sources because no retained direct positive evidence is provided inside the recent evidence window.

Why now: No current catalyst can be established from the reviewed sources; the company has zero evidence after recent evidence window.

Caveats: Phase-2 rationale says York Space Systems acquired Solestial and cites: but no article summary or is provided here, so it cannot be used as cited factual support. Coverage debug shows 4 articles considered and 0 article IDs after recent evidence window. Absence of evidence is not positive or negative proof.

372
Solstar Space Company
lowweak
Opp 1
Risk 1

Thesis: The membership rationale says Solstar's Deke Space Communicator operated in orbit and achieved TRL 9 with two-way data transmission and onboard Wi-Fi, which could imply commercialization potential, but no direct positive evidence or article summaries are available for scoring in these reviewed sources.

Why now: The reviewed sources contain no reviewed evidence after recent evidence window for this company, preventing a recency-based 1 year+ ranking judgment beyond watchlist status.

Caveats: Membership rationale references article, but no direct summary or evidence row is available here for citation. Coverage debug shows zero available evidence after recent evidence window. Private-company status is not itself positive or negative.

373
Space Systems/Loral, LLC (SSL)
lowweak
Opp 1
Risk 1

Thesis: SSL is referenced in membership rationale as appearing among key players in an optical satellite market report, but that is only article-level industry context and no direct within the recent evidence window evidence is available.

Why now: No current catalyst can be established because coverage debug shows 0 article IDs after recent evidence window and 0 evidence after recent evidence window. The rationale cites: without a in these reviewed sources.

Caveats: Only industry-report context is referenced in membership rationale. No direct event/fact evidence survived the recent evidence window.

374
Space42
lowweak
Opp 1
Risk 1

Thesis: Space42 is described in membership rationale as operating a SAR Earth observation constellation with satellites entering full operation, but the reviewed sources retains no direct evidence or article summaries within the recent evidence window to support a current opportunity ranking.

Why now: Why now is weak because coverage data shows no articles after recent evidence window and no evidence after recent evidence window.

Caveats: Membership rationale references article IDs but no are provided, so they cannot be used as cited factual support here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0.

375
SpaceLocker
lowweak
Opp 1
Risk 1

Thesis: There is not enough retained evidence in the recent evidence window to underwrite a durable opportunity case, despite membership rationale describing a first shared satellite mission.

Why now: No article-level or event-level evidence were retained after the March 29, 2026 recent evidence window cutoff; recency for the membership rationale is therefore unusable for ranking.

Caveats: Membership rationale references article, but no representative article summary or retained evidence row is included. Single-article universe with zero retained rows limits confidence materially.

376
SpaceLogistics (Northrop Grumman)
lowweak
Opp 1
Risk 2

Thesis: The reviewed sources contain a descriptive article saying SpaceLogistics provides cooperative in-orbit satellite servicing using commercial servicing vehicles, which supports strategic relevance as a business category, but the only cited article is dated March 4, 2025 and was dropped by the 90-day recent evidence window.

Why now: Why now is weak because the only cited article, March 4, 2025), falls outside the 90-day recent evidence window and was dropped; recency therefore does not support an active thesis here.

Caveats: No evidence were kept after recent evidence filtering. Cannot rely on dropped 2025 evidence for a current ranking. Company-category relevance is not sufficient for a directional opportunity thesis.

377
Spaceworks
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources only says Momentus's fully booked Vigoride 8 mission will carry a Spaceworks COSMIC payload, which indicates some space-payload involvement but does not establish a durable company-specific opportunity thesis for Spaceworks.

Why now: No within the recent evidence window retained catalyst is available. The phase-2 rationale references, but no, timestamp, or retained summary is included.

Caveats: Support is provisional single-article context only. No retained direct evidence after recent evidence window. Payload mention does not prove company-level commercial traction.

378
Spacium
lowweak
Opp 1
Risk 2

Thesis: Spacium has a potentially attractive refueling/logistics angle, and an older article says it raised an oversubscribed $6.3 million seed round, but that dated evidence is outside the 90-day recent evidence window and therefore cannot support a current-ranked opportunity thesis.

Why now: The only cited article is dated January 23, 2025, and the reviewed sources explicitly shows it was dropped by the 90-day recent evidence window cutoff of March 29, 2026.

Caveats: All dated evidence was excluded by recent evidence window. Do not use out-of-window article as current recency proof.

379
SSC Space
lowweak
Opp 1
Risk 1

Thesis: No positive thesis is supportable from these reviewed sources because no direct positive evidence remains after recent evidence filtering.

Why now: There is no retained within the recent evidence window evidence for a current catalyst.

Caveats: Phase-2 rationale mentions a sponsored article and a partnership supporting Firefly's Blue Ghost lunar lander antennas, citing, but no or article summary is provided in these reviewed sources. Coverage debug shows 3 articles considered and 0 after recent evidence window. Sponsored-article context would be weaker than direct event/fact evidence even if fully provided.

380
ST Engineering
lowweak
Opp 1
Risk 1

Thesis: Only weak, supporting article context suggests ST Engineering had involvement in SAR and AI geospatial analytics for satellite ocean surveillance, but the reviewed sources contain no direct positive evidence after the 90-day recent evidence window and no article to substantiate a durable 1 year+ opportunity thesis (: not provided in reviewed sources).

Why now: There is no usable dated direct evidence inside the recent evidence window; the reviewed sources explicitly shows articles after recent evidence window = 0 and evidence after recent evidence window = 0, so recency-based timing is unsupported.

Caveats: No direct evidence remained after the recent evidence filter. Representative articles are empty, so no is available in the reviewed sources. Membership rationale is weaker than company-specific event evidence.

Risk view

Showing rows 221-240 of 438; 20 rows per page.

Sorted by raw risk score
RankCompanyScoreThesis / Evidence
221
Spacety
lowweak
Opp 2
Risk 2

Thesis: There is no usable in-window article or evidence detail in the reviewed sources to validate the company’s current operating status, financing trajectory, or any adverse development, so the main risk is evidence absence rather than proven business trouble.

Why now: There is no dated evidence retained after recent evidence window for Spacety in these reviewed sources. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency is uncertain.

Caveats: No representative articles or evidence are provided after recent evidence window. The only support is the phase2 membership rationale, which is weaker than direct event/fact evidence and does not provide /article summaries here. Because there is no in-window evidence, scores remain low on both axes.

222
Spacium
lowweak
Opp 1
Risk 2

Thesis: No direct negative evidence is present; the main issue is stale evidence and resulting uncertainty about current momentum or business state.

Why now: The only cited article is dated January 23, 2025, and the reviewed sources explicitly shows it was dropped by the 90-day recent evidence window cutoff of March 29, 2026.

Caveats: All dated evidence was excluded by recent evidence window. Do not use out-of-window article as current recency proof.

223
SpinLaunch
lowweak
Opp 2
Risk 2

Thesis: Novel launcher and constellation buildout imply execution risk, but these reviewed sources provide no direct negative evidence within the recent evidence window.

Why now: Why-now is weak because the reviewed sources show 0 evidence kept after the 90-day recent evidence window, so recency cannot be established from local evidence.

Caveats: Phase2 membership rationale references and, but no article summaries or direct evidence are included, so they cannot be cited as factual support beyond noting the reviewed sources rationale. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Opportunity score kept low because positive thesis is not directly grounded in usable article evidence in these reviewed sources.

224
SSC Space
lowweak
Opp 2
Risk 2

Thesis: Reviewed evidence risk is mainly lack of evidence visibility rather than documented negative developments. Without available direct evidence, current contract status, capex burden, and follow-on demand are unclear.

Why now: Why now is weak because no evidence survived into the ranking reviewed sources despite the membership rationale.

Caveats: Phase-2 membership rationale references: but no or direct evidence row is available here. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Do not infer opportunity from mission association alone without available evidence.

225
Star Catcher Industries, Inc.
lowweak
Opp 1
Risk 2

Thesis: Risk is mostly uncertainty risk because no kept recent evidence window evidence establish financing, contracts, milestones, or adverse developments.

Why now: Why now is weak because the reviewed sources' membership rationale references article describing an orbital power grid concept, but no article or reviewed evidence are provided for ranking use.

Caveats: No article is available for article. Coverage debug shows zero evidence after recent evidence window. Cannot elevate concept relevance into thesis attractiveness without direct business evidence.

226
Starcloud
lowweak
Opp 4
Risk 2

Thesis: The same rationale suggests category ambiguity and execution risk: orbital AI/data-center activity may be conceptually ambitious, but the reviewed sources does not prove commercialization, deployment, or durable demand. No direct adverse evidence is available, so risk remains moderate and evidence-light rather than event-driven.

Why now: If the fundraising and product positioning are recent, they could support a multi-quarter buildout story, but the reviewed sources explicitly shows zero available evidence after recent evidence window, so recency and sequencing cannot be confirmed.

Caveats: Most supportive facts appear only in membership rationale, not available evidence. Reported funding cannot be treated as fully validated without direct article support in reviewed sources. No, quote, or dated direct summary is available.

227
Stelleo
lowweak
Opp 4
Risk 2

Thesis: Risk remains modest because the reviewed sources offers no adverse evidence, but also no proof of contracts, funding, customer traction, or scaling milestones. That makes the opportunity early-stage and low-conviction.

Why now: The article is within the recent evidence window and dated May 25, 2026, but it is a company-site style description rather than an independently reported business event, so it supports relevance more than momentum

Evidence
  • Article describes Stelleo as a Polish Earth Observation startup that turns satellite data into operational decisions and says it provides protection for infrastructure, harvests, and operations across Europe; May 25, 2026. stelleo.eu

Caveats: Evidence is article-level company context, not a direct commercial milestone. No direct traction, financing, or contract evidence is provided. Same-article repeated rows are not independent confirmation.

228
SWISSto12
lowweak
Opp 3
Risk 2

Thesis: The reviewed sources contain no retained article/evidence detail after recent evidence window to confirm deliveries, customer adoption, financing, or execution setbacks, so business risk cannot be judged confidently.

Why now: There is no dated evidence retained after recent evidence window for SWISSto12. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so the timing case is not established from these reviewed sources.

Caveats: Assessment relies only on the reviewed sources' membership rationale, not direct quoted event/fact evidence with support. No representative articles are included despite article IDs being referenced in the rationale. Potential opportunity could be meaningful, but evidentiary support inside these reviewed sources is too thin for a stronger score.

229
Terran Orbital
lowweak
Opp 1
Risk 2

Thesis: Risk scores slightly above minimal only because evidence absence is meaningful for ranking confidence and because the reviewed sources gives no current direct positive operating or contract evidence inside the recent evidence window. There is still no direct adverse event in the reviewed sources.

Why now: There is no valid near-term or long-horizon catalyst from the reviewed sources because coverage data shows zero evidence after recent evidence window; current state cannot be confirmed from local evidence.

Caveats: No evidence remained after the 90-day recent evidence window. The reviewed sources includes only sparse membership rationale, not current direct evidence.

230
The Exploration Company
lowweak
Opp 5
Risk 2

Thesis: Main risk is evidence thinness and uncertain recency: the reviewed sources contain no direct negative evidence, but the only business evidence is undated supporting article context, so current contract status and execution progress are uncertain.

Why now: Why now is weak: the only cited catalyst is an undated article stating the company won an ESA cargo contract, and the reviewed sources provide no newer dated confirmation within the 90-day window. Recency-sensitive conclusions should therefore be cautious.

Evidence
  • The Exploration Company was contracted by the European Space Agency to develop a Low Earth Orbit cargo return service, and the article says it was ranked first and awarded the contract. tech.eu

Caveats: Only undated article-context evidence is present; no direct structured positive event/facts survived. The reviewed sources includes no within the recent evidence window dated follow-up on financing, program execution, or milestone delivery. Article-level context is weaker than direct company event/fact evidence.

231
True Anomaly Centennial
lowweak
Opp 3
Risk 2

Thesis: Risk remains moderate because the reviewed sources provide no direct available evidence after recent evidence window to confirm award economics, schedule, or follow-on conversion.

Why now: Government program selection could matter over 1 year+, but the reviewed sources does not provide surviving evidence with timing details after recent evidence window.

Caveats: No -bearing direct evidence row is available for the referenced Andromeda selection article. Selection does not prove revenue realization or contract scale.

232
Umbra
mediummedium
Opp 5
Risk 2

Thesis: The main risk in these reviewed sources is evidentiary rather than business-specific: there is no direct negative evidence, but also no direct structured positive event row such as a contract, financing, or milestone within the recent evidence window. Opportunity therefore rests on supporting article context rather than stronger company-specific event evidence.

Why now: The most recent dated context is June 22, 2026, which is within the 90-day recent evidence window and indicates Umbra currently operates a SAR constellation and serves government and commercial customers. However, no nearer-term catalyst row is available, so the timing case is moderate rather than strong.

Evidence
  • Published June 22, 2026: Umbra is described as a U.S. commercial space company developing and operating a SAR satellite constellation that delivers rapid, regular, and high-resolution data to public and private customers. eoportal.org

Caveats: Evidence is supporting article context/weak context only, not a direct structured positive event row. The July 31, 2024 Umbra article is outside the 90-day dated recent evidence window and was dropped for recency-sensitive scoring.

233
United Launch Alliance
lowweak
Opp 2
Risk 2

Thesis: No material adverse evidence is available, so there is no supported negative thesis from these reviewed sources alone.

Why now: The membership rationale cites articles: and: but no article summaries or evidence are available after recent evidence filtering for ranking.

Caveats: Launch-industry membership is not itself a directional thesis. Coverage debug shows zero evidence after recent evidence window despite many considered articles. No direct contract, launch cadence, backlog, or failure evidence is available in these reviewed sources.

234
Viasat, Inc.
mediummedium
Opp 4
Risk 2

Thesis: Risk remains moderate because the reviewed sources provide only weak supporting article context rather than direct structured company events, limiting confidence in scope, economics, and timing of impact.

Why now: Recent context exists within the recent evidence window: is dated June 11, 2026 and states Viasat was among operators selected under a combined $437.7 million award and has a defined supplier stack for its PTS-G satellite, which could matter over a 1 year+ horizon. Source date basis is source date.

Evidence
  • Rocket Lab will supply the spacecraft bus for Viasat’s PTS-G satellite, and the article says communications satellite operators SES and Viasat were selected as prime contractors under a combined $437.7 million award to each build and operate a satellite. spacenews.com

Caveats: This is supporting article context only; the reviewed sources classifies it under weak context, so it is weaker than direct event/fact evidence. Same article appears in two weak-context rows and should not be treated as independent confirmation. An older Viasat company-hosted article exists but is outside recent evidence window, February 29, 2024

235
Voyager Technologies Inc.
lowweak
Opp 2
Risk 2

Thesis: A mild risk prior exists only from uncertainty: despite many articles considered, no retained evidence remains after recent evidence window, so no current adverse thesis is established and business-state recency is unclear.

Why now: There is no citable within the recent evidence window evidence in the reviewed sources to justify a strong 1 year+ 'why now' despite broad historical article coverage.

Caveats: Phase-2 rationale references: and: but no or summaries are provided here. Coverage debug shows 78 articles considered but 0 article IDs after recent evidence window and 0 available evidence. Ticker ambiguity exists in aliases (VOYG, VYGR), but the required output ticker is VOYG.

236
VSBLTY Groupe Technologies Corp.
lowweak
Opp 2
Risk 2

Thesis: The same rationale implies adjacency rather than a clearly established core space operator role, creating execution and relevance risk, but no material adverse event evidence is available after recent evidence filtering.

Why now: No reviewed sources-grounded timing support is available for why this matters now over a 1 year+ horizon; the reviewed sources retains zero evidence after the cutoff and provides no citable for article.

Caveats: Reviewed evidence is limited to a membership rationale; there are no representative article summaries, or evidence after recent evidence window. The cited article id is not accompanied by a in the reviewed sources, so it cannot be used for factual claim citation. Slightly higher opportunity/risk than some peers reflects adjacency language in the reviewed sources rationale only, not strong direct evidence.

237
Xdlinx
lowweak
Opp 2
Risk 2

Thesis: No direct negative evidence is present; the practical risk to ranking is simply insufficient current evidence.

Why now: The reviewed sources includes no representative article or retained evidence within the 90-day recent evidence window, so recency and current status are uncertain for Xdlinx in this screen.

Caveats: No retained evidence after recent evidence window. Phase-2 membership support alone is not enough for a stronger score.

238
XDLINX Space Labs
lowweak
Opp 2
Risk 2

Thesis: Risk is modestly elevated versus some peers because the company appears only once in the reviewed sources, and the lack of retained recent evidence means the claimed business standing cannot be validated or updated within the recent evidence window.

Why now: No current catalyst is evidenced; coverage after recent evidence window is empty.

Caveats: Reviewed evidence mentions: but provides no. Higher-revenue claim is only from membership rationale and may not be current. No retained structured positive or negative evidence after recent evidence window.

239
Xona Space
lowweak
Opp 3
Risk 2

Thesis: Risk is mainly execution and proof-of-delivery risk because the surviving evidence is undated company context without dated commercial milestones, customers, or financing in the reviewed sources.

Why now: Why now is weak: the only surviving evidence is undated, so recency-sensitive claims are uncertain

Evidence
  • Company context says Xona Pulsar is low-Earth-orbit positioning, navigation, and timing infrastructure with 258 small satellites; evidence is undated supporting article context. xonaspace.com

Caveats: Evidence is undated and should not be treated as recency proof. No direct positive event or traction evidence is available. Opportunity case is strategic but low-conviction.

240
ADAspace
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available within the reviewed sources' recent evidence window. Risk remains low-scored due to lack of evidence rather than demonstrated safety.

Why now: There is no usable within the recent evidence window evidence in the reviewed sources; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for ADAspace.

Caveats: Phase-2 membership rationale references article: but the reviewed sources provide no for citation. No direct positive or negative evidence survived the 90-day recent evidence window.